ErlySign secures ₹16 Cr in funding for next-gen diagnostics 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection
ErlySign secures ₹16 Cr in funding for next-gen diagnostics 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection
ErlySign secures ₹16 Cr in funding for next-gen diagnostics 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection 'Big Whale' invests in Curo Biosciences Lumos Health Accelerator onboards startups in early cancer detection

Detect Oral Cancer Early and Save Lives

Use saliva-based detection to flag risks early and reinforce your role in life-saving care.

What is Oral Cancer?

Oral cancer refers to malignancies of the lips, tongue, cheeks, floor of the mouth, and throat. It often goes unnoticed until advanced stages, making it one of the deadliest yet most preventable cancers when detected early.

A deadly disease that starts silently.

How Big is the Problem?

The data is alarming. The risk is real.

0 Million+

Global Cases

Spreading silently, faster each year.

0 %

from India

The highest share worldwide.

0 %

Diagnosed Late

Too late for simple care.

0 %

Mortality Rate

More deaths than recoveries.

0 %

Unnecessary Scans

Costly tests often avoidable.

0 %

Deaths Preventable

with early screening.

Who is at Risk?

Understanding the most vulnerable to oral cancer.

Tobacco & Areca Nut Use

flipbox-image

Tobacco & Areca Nut Use

Whether smoked, chewed or in gutka from, these are the top causes of oral cancer in india.
  • Prolonged exposure causes DNA damage.
  • Often starts early in adolescence.
57%
of oral cancer cases are linked to tobacco and areca nut consumption

Alcohol Consumption

flipbox-image

Alcohol Consumption

Whether frequent or occasional, alcohol use increases the risk of oral cancers—especially when combined with tobacco.
  • Irritates mouth lining, making it more vulnerable
  • Often masks early symptoms during routine check-ups
34%
of oral cancer cases involve heavy or prolonged alcohol use.

Sharp Teeth or Ill-Fitting Dentures

flipbox-image

Sharp Teeth or Ill-Fitting Dentures

Chronic irritation from sharp teeth or poor dental fittings can damage oral tissues and increase cancer risk.
  • Continuous friction leads to cellular changes.
  • Risk amplifies with poor oral hygiene.
1 in 10
oral cancer patients report persistent mouth irritation as a contributing factor.

Poor Diet & Nutrition

flipbox-image

Poor Diet & Nutrition

A lack of fruits, vegetables, and essential micronutrients can weaken your body’s natural defenses.
  • Deficiencies impair tissue repair and immunity.
  • Diets high in processed foods elevate risk.
43%
of cases are associated with nutritional deficiencies.

HPV (Human Papillomavirus)

flipbox-image

HPV (Human Papillomavirus)

This sexually transmitted virus can infect the mouth and throat, significantly increasing cancer risk.
  • Strains like HPV-16 are high-risk for oral cancers.
  • Often asymptomatic in early stages.
70%
of oropharyngeal cancers are linked to HPV infections.

Weakened Immune System

flipbox-image

Weakened Immune System

Conditions or treatments that suppress the immune system reduce the body’s ability to fight abnormal cell growth.
  • Includes HIV/AIDS, chemotherapy, or post-transplant drugs.
  • Heightens vulnerability to persistent infections.
3x
higher risk of oral cancer in immunocompromised individuals.

UV Exposure

flipbox-image

UV Exposure

Prolonged sun exposure puts your lips at risk—especially for those working outdoors without protection.
  • Damages skin cells on the lips.
  • Common among farmers, construction workers, and outdoor vendors.
65%
of lip cancer cases are traced to chronic UV exposure.

Our Solution

A Breakthrough in Oral Cancer Detection

The ErlySign Oral Cancer Detection Kit is a revolutionary, saliva-based detection tool designed to detect early-stage oral cancer painlessly, accurately, and affordably.

0 %

More Affordable Than Biopsy

Cost advantage of our kit

0 %

Detection Accuracy

Clinically tested precision level

0 -Min

Test Results

Quick, lab-free diagnosis

0 %

early-stage detection

In partners using ErlySign

How It Works?

A revolutionary 6-step process. No pain. No blood.

How do we assess the risk?

Non-Invasive Testing

No needles, no pain just saliva.

Remote Monitoring

Track post-op patients from home.

Boost Patient Trust

Offer cutting-edge care confidently.

Fast Turnaround

Get results in under 15 minutes.

New Revenue Channel

Affordable pricing and scalable adoption.

Nationwide Impact

Part of India’s biggest early detection program.

Built for Better Outcomes

ErlySign’s non invasive, saliva based oral cancer detection kit identifies high risk lesions with precision before symptoms appear.

Why Partner with us ?

Partner with us to bring cutting edge, non invasive early detection to more people.

Life-Saving Innovation

Non-invasive, portable, fast testing.

Plug-and-Play Simplicity

No large machines or complex procedures

Scalable for Everyone

Designed for hospitals, labs, and clinics—urban or rural

Impact at Scale

can help save 1 million+ lives annually

Erlysign is a non invasive early detection test kit for detecting Oral precancerous conditions at an early stage.

This is a semi quantitative test in which we check for biomarkers in one’s saliva sample to assess the risk of pre cancerous conditions .The results can be quantified as Low - Moderate - High depending on the assessment.

No this is an early detection test and is meant to assess the risk of oral precancerous conditions and its ongoing or future development. This test is not meant to diagnose the cancer.Only Biopsies can confirm the cancer.

Our kit offers 98.04% clinically validated accuracy, making it a highly reliable non-invasive detection tool.

Frequently Asked Questions

Get quick answers about our early detection solution and partnership opportunities.

Coming Soon:

ErlySign multi cancer detection kit™

We’re developing a breakthrough that will screen for multiple cancers using just your saliva. With CRISPR technology at its core, early detection is about to get simpler, faster, and far more powerful.

Painless, Non-Invasive Testing

A simple saliva sample is the only requirement

Skip Unnecessary Procedures

Reduce biopsies and PET scans by 60% in suspected cases.

Simplify post operative monitoring

Allow post-operative patients to be monitored from home, hassle free.

Be the First to Act

Add value driven solution to your offerings, no added infrastructure.

Be the First to Know

Get Started with ErlySign

Fill in your details to explore how your clinic, lab, or hospital can integrate saliva-based early detection effortlessly.